PERSPECTA

News from every angle

Back to headlines

Cumberland Pharmaceuticals Reports Q2 Financial Results

Cumberland Pharmaceuticals released its second-quarter earnings, reporting a Non-GAAP EPS of -$0.20 and revenue of $166.46 million.

4 Aug, 21:28 — 4 Aug, 21:28
PostShare

Sources

Showing 1 of 1 sources